Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.
about
Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyFVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.
P2860
Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of Recombinant Virus Repli ...... ycobacterium ulcerans Disease.
@ast
Use of Recombinant Virus Repli ...... ycobacterium ulcerans Disease.
@en
type
label
Use of Recombinant Virus Repli ...... ycobacterium ulcerans Disease.
@ast
Use of Recombinant Virus Repli ...... ycobacterium ulcerans Disease.
@en
prefLabel
Use of Recombinant Virus Repli ...... ycobacterium ulcerans Disease.
@ast
Use of Recombinant Virus Repli ...... ycobacterium ulcerans Disease.
@en
P2093
P2860
P1476
Use of Recombinant Virus Repli ...... Mycobacterium ulcerans Disease
@en
P2093
Gerd Pluschke
Miriam Bolz
Sarah Kerber
P2860
P304
P356
10.1371/JOURNAL.PNTD.0004011
P407
P50
P577
2015-08-14T00:00:00Z